PDB Short entry for 2WKM HEADER TRANSFERASE 15-JUN-09 2WKM TITLE X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TYROSINE KINASE DOMAIN, UNP RESIDUES 1051-1348; COMPND 5 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF RECEPTOR, HGF/SF COMPND 6 RECEPTOR, MET PROTO-ONCOGENE TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS HEPATOCYTE GROWTH FACTOR RECEPTOR, C-MET, KINASE, INHIBITOR, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.MCTIGUE,N.GRODSKY,K.RYAN,J.J.CUI REVDAT 4 13-DEC-23 2WKM 1 REMARK REVDAT 3 08-MAY-19 2WKM 1 REMARK REVDAT 2 28-SEP-11 2WKM 1 AUTHOR JRNL REMARK FORMUL REVDAT 2 2 1 HETATM VERSN REVDAT 1 25-AUG-10 2WKM 0 JRNL AUTH J.J.CUI,M.TRAN-DUBE,H.SHEN,M.NAMBU,P.P.KUNG,M.PAIRISH,L.JIA, JRNL AUTH 2 J.MENG,L.FUNK,I.BOTROUS,M.MCTIGUE,N.GRODSKY,K.RYAN, JRNL AUTH 3 E.PADRIQUE,G.ALTON,S.TIMOFEEVSKI,S.YAMAZAKI,Q.LI,H.ZOU, JRNL AUTH 4 J.CHRISTENSEN,B.MROCZKOWSKI,S.BENDER,R.S.KANIA,M.P.EDWARDS JRNL TITL STRUCTURE BASED DRUG DESIGN OF CRIZOTINIB (PF-02341066), A JRNL TITL 2 POTENT AND SELECTIVE DUAL INHIBITOR OF JRNL TITL 3 MESENCHYMAL-EPITHELIAL TRANSITION FACTOR (C-MET) KINASE AND JRNL TITL 4 ANAPLASTIC LYMPHOMA KINASE (ALK). JRNL REF J.MED.CHEM V. 54 6342 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21812414 JRNL DOI 10.1021/JM2007613 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 200.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 15892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.300 REMARK 3 FREE R VALUE TEST SET COUNT : 770 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2084 REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 93 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2284 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.03400 REMARK 3 B22 (A**2) : 0.32800 REMARK 3 B33 (A**2) : -0.36300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.600 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 58.44 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : PFE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WKM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1290040011. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-06 REMARK 200 TEMPERATURE (KELVIN) : 85 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19501 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 37.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 2WGJ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED AT 13 DEGREES C REMARK 280 BY THE HANGING DROP VAPOR DIFFUSION METHOD USING 1.2 MICROLITERS REMARK 280 OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD PLUS A 5 REMARK 280 FOLD MOLAR EXCESS OF PHA-00665752) AND 1.2 MICROLITERS OF MOTHER REMARK 280 LIQUOR SOLUTION (0.05 M CITRATE-PHOSHPHATE 4.6, 0-0.275 M NACL, REMARK 280 AND 21% W/V PEG 3350)., PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.71750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.89350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.71750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.89350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 GLY A 1346 REMARK 465 GLU A 1347 REMARK 465 HIS A 1348 REMARK 465 HIS A 1349 REMARK 465 HIS A 1350 REMARK 465 HIS A 1351 REMARK 465 HIS A 1352 REMARK 465 HIS A 1353 REMARK 465 HIS A 1354 REMARK 465 HIS A 1355 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A1345 CA C O CB CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1101 44.45 -97.00 REMARK 500 SER A1149 -85.98 -70.50 REMARK 500 ARG A1203 -15.17 82.50 REMARK 500 ASP A1204 42.35 -145.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 1102 LYS A 1103 -145.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PFY A 2345 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE REMARK 900 GROWTH FACTOR RECEPTOR C-MET REMARK 900 RELATED ID: 1UX3 RELATED DB: PDB REMARK 900 3D STRUCTURE PREDICTION OF AMINO ACIDS 25 TO 656 OF HUMAN REMARK 900 HEPATOCYTE GROWTH FACTOR/ SCATTER FACTOR (MET) RECEPTOR REMARK 900 RELATED ID: 2WGJ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET REMARK 900 RELATED ID: 1FYR RELATED DB: PDB REMARK 900 DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTALSTRUCTURE OF REMARK 900 THE GRB2-SH2 AC- PYVNV COMPLEX REMARK 900 RELATED ID: 2WD1 RELATED DB: PDB REMARK 900 HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR REMARK 900 RELATED ID: 2UZX RELATED DB: PDB REMARK 900 STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH REMARK 900 THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: CRYSTAL FORM I REMARK 900 RELATED ID: 1SHY RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HGF BETA-CHAIN IN COMPLEX WITH THESEMA REMARK 900 DOMAIN OF THE MET RECEPTOR. REMARK 900 RELATED ID: 2CEW RELATED DB: PDB REMARK 900 3D STRUCTURE PREDICTION OF THE IG2-IG4 DOMAINS OF THE ECTODOMAIN REMARK 900 REGION OF THE HUMAN HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR REMARK 900 RECEPTOR, MET REMARK 900 RELATED ID: 2UZY RELATED DB: PDB REMARK 900 STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH REMARK 900 THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: LOW RESOLUTION, REMARK 900 CRYSTAL FORM II REMARK 900 RELATED ID: 1SSL RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PSI DOMAIN FROM THE MET RECEPTOR REMARK 900 RELATED ID: 2G15 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C- MET KINASE REMARK 900 RELATED ID: 1R0P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE REMARK 900 GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITHTHE MICROBIAL ALKALOID REMARK 900 K-252A REMARK 999 REMARK 999 SEQUENCE REMARK 999 UNIPROT ENTRY P08581 HAS A VAL 1272 LEU CONFLICT DBREF 2WKM A 1051 1348 UNP P08581 MET_HUMAN 1051 1348 SEQADV 2WKM MET A 1050 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1349 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1350 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1351 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1352 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1353 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1354 UNP P08581 EXPRESSION TAG SEQADV 2WKM HIS A 1355 UNP P08581 EXPRESSION TAG SEQRES 1 A 306 MET VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU SEQRES 2 A 306 VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER SEQRES 3 A 306 LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS SEQRES 4 A 306 PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP SEQRES 5 A 306 GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG SEQRES 6 A 306 ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU SEQRES 7 A 306 GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SEQRES 8 A 306 SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO SEQRES 9 A 306 LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG SEQRES 10 A 306 ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS SEQRES 11 A 306 ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET SEQRES 12 A 306 LYS TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU SEQRES 13 A 306 ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL SEQRES 14 A 306 LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP SEQRES 15 A 306 LYS GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS SEQRES 16 A 306 LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR SEQRES 17 A 306 GLN LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY SEQRES 18 A 306 VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO SEQRES 19 A 306 TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU SEQRES 20 A 306 LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO SEQRES 21 A 306 ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO SEQRES 22 A 306 LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER SEQRES 23 A 306 ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS SEQRES 24 A 306 HIS HIS HIS HIS HIS HIS HIS HET PFY A2345 43 HETNAM PFY (3Z)-5-[(2,6-DICHLOROBENZYL)SULFONYL]-3-[(3,5-DIMETHYL- HETNAM 2 PFY 4-{[(2S)-2-(PYRROLIDIN-1-YLMETHYL)PYRROLIDIN-1- HETNAM 3 PFY YL]CARBONYL}-1H-PYRROL-2-YL)METHYLIDENE]-1,3-DIHYDRO- HETNAM 4 PFY 2H-INDOL-2-ONE FORMUL 2 PFY C32 H34 CL2 N4 O4 S FORMUL 3 HOH *165(H2 O) HELIX 1 1 ASN A 1059 VAL A 1069 1 11 HELIX 2 2 GLY A 1072 SER A 1074 5 3 HELIX 3 3 ASP A 1117 ILE A 1129 1 13 HELIX 4 4 ILE A 1130 PHE A 1134 5 5 HELIX 5 5 ASP A 1164 ASN A 1171 1 8 HELIX 6 6 THR A 1177 LYS A 1198 1 22 HELIX 7 7 ALA A 1206 ARG A 1208 5 3 HELIX 8 8 PHE A 1223 ARG A 1227 5 5 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ASP A 1291 GLN A 1298 1 8 HELIX 13 13 PRO A 1309 TRP A 1320 1 12 HELIX 14 14 LYS A 1323 ARG A 1327 5 5 HELIX 15 15 SER A 1329 THR A 1343 1 15 SHEET 1 AA 6 VAL A1070 ILE A1071 0 SHEET 2 AA 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA 6 LEU A1154 PRO A1158 -1 O LEU A1154 N CYS A1146 SHEET 4 AA 6 LYS A1104 SER A1111 -1 O ALA A1108 N LEU A1157 SHEET 5 AA 6 GLY A1090 LEU A1098 -1 O CYS A1091 N SER A1111 SHEET 6 AA 6 LEU A1076 GLY A1087 -1 O ILE A1077 N THR A1096 SHEET 1 AB 2 CYS A1210 LEU A1212 0 SHEET 2 AB 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 15 VAL A1092 ALA A1108 LEU A1140 PRO A1158 SITE 2 AC1 15 TYR A1159 MET A1160 LYS A1161 HIS A1162 SITE 3 AC1 15 GLY A1163 ASN A1209 MET A1211 ALA A1221 SITE 4 AC1 15 ASP A1222 ALA A1226 TYR A1230 CRYST1 77.435 95.787 45.601 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012914 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010440 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021929 0.00000